August 24, 2011 — Physio-Control Inc. announced commercial availability of the ReadyLink 12-lead electrocardiogram (ECG) device. It is a new U.S. Food and Drug Administration (FDA) 510(k)-cleared solution designed to improve care for heart attack patients and expand regional ST-segment elevated myocardial infarction (STEMI) systems.
